Remarkable: Pembrolizumab (Keytruda) now also for advanced non-small cell lung cancer (NSCLC)
October 06, 2015 – Lung cancer is the leading cause of cancer death in the United States, with an estimated 221,200 new diagnoses and 158,040 deaths in 2015, according to the National Cancer Institute. Among lung cancers, non-small cell lung …